Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
9.33B
Market cap9.33B
Price-Earnings ratio
41.78
Price-Earnings ratio41.78
Dividend yield
Dividend yield
Average volume
389.47K
Average volume389.47K
High today
$319.48
High today$319.48
Low today
$312.00
Low today$312.00
Open price
$315.25
Open price$315.25
Volume
373.89K
Volume373.89K
52 Week high
$319.48
52 Week high$319.48
52 Week low
$122.80
52 Week low$122.80

Stock Snapshot

The current Krystal Biotech(KRYS) stock price is $316.30, with a market capitalization of 9.33B. The stock trades at a price-to-earnings (P/E) ratio of 41.78.

As of 2026-05-14, Krystal Biotech(KRYS) stock has fluctuated between $312.00 and $319.48. The current price stands at $316.30, placing the stock +1.4% above today's low and -1.0% off the high.

Krystal Biotech(KRYS) shares are trading with a volume of 373.89K, against a daily average of 389.47K.

During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $319.48 at its peak.

During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $319.48 at its peak.

KRYS News

Simply Wall St 1d
There May Be Underlying Issues With The Quality Of Krystal Biotech's Earnings

Krystal Biotech, Inc. ( ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift in the share price. However, we think tha...

There May Be Underlying Issues With The Quality Of Krystal Biotech's Earnings
Investor's Business Daily 3d
This Profitable Biotech Stealthily Climbs Into A Buy Zone

Biotech Stock Nears Entry After FDA News; Earnings On Horizon 2/10/2026 Krystal Biotech is engaged in developing genetic medicines. The biotech stock is near a...

This Profitable Biotech Stealthily Climbs Into A Buy Zone
Simply Wall St 5d
A Look At Krystal Biotech Valuation After Vyjuvek Powered Q1 2026 Earnings Beat

Advertisement Why Krystal Biotech’s latest earnings are moving the stock Krystal Biotech (KRYS) is back on investors’ radar after Q1 2026 earnings topped expe...

A Look At Krystal Biotech Valuation After Vyjuvek Powered Q1 2026 Earnings Beat

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.